Laxmi Dental share price today

Laxmi Dental Ltd's share price was ₹188.71 at the close on 4 November 2026. It has been falling for 93 weeks. That is 15.3% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹162 and ₹342, and at that close it sat 15% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Laxmi Dental Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row.

Over the last 1 year the share price moved −63% while the NIFTY 500 moved +3%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Foreign funds (FIIs) cut their stake for 3 quarters in a row

   From 32.5% to 6.6% of the company by the September 2026 quarter.

3. Revenue up on a year earlier for 7 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹75 crore, +13.6% on a year earlier.

   Why: Revenue rose because the dental laboratory business sold more at home and abroad.

   Next results: check whether domestic laboratory growth picks up in Q2 as new scanner users mature.

   From the earnings call on 12 Aug 2026.

For April to June 2026 (the quarter ended 30 June 2026), Laxmi Dental reported revenue of ₹75.0 crore, up 13.6% from ₹66.0 crore a year earlier, and a profit of ₹10.0 crore, up 25.0% from ₹8.00 crore.

Laxmi Dental results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Laxmi Dental's management discussed these results on a call held on 12 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Laxmi Dental closed at ₹188.71 on 4 November 2026, down 39.5% from ₹311.80 a year earlier (7 November 2025). Its highest weekly close since January 2025 was ₹514.10 on 24 January 2025.

Laxmi Dental share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

100 weekly closes from 24 January 2025 to 4 November 2026.

4 Nov 2026: Laxmi Dental closed at ₹188.71, up 6.3% on the week and down 2.7% on the month. 12 Aug 2026: Laxmi Dental held its results call for April to June 2026. Management guided: Revenue growth 15-20% and margins 18-20% for the current year; described as an aspiration.

Earlier

• Results for April to June 2026: Revenue up 13.6% and profit up 25.0% on a year earlier.

Laxmi Dental has paid no dividend on the NSE since its first NSE close in our records (24 January 2025), the start of the period we checked.

No. Laxmi Dental Ltd paid out 0% of its profit as dividends in each of its last 7 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 12 August 2026, Laxmi Dental's management guided: Revenue growth 15-20% and margins 18-20% for the current year; described as an aspiration.

“On the aspiration side, we had said that our goal was revenue growth of 15-20% and margins of 18-20%.”Dharmesh Dattani, CFO, on the call for April to June 2026

What management guided

• Scanner deployment 800-1,000 in the financial year.
• Domestic laboratory growth to move upward through Q2-Q4 as scanner cohorts mature.
• Aligner growth momentum to continue, supported by 2-3 initiatives over the next few quarters.
• AI-led automation costs to become much lower next year as beta AI-crown activity scales.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 12 August 2026.

When Laxmi Dental reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Domestic laboratory growth to inflect in Q2; check whether scanner cohorts produce the stated acceleration.

Laxmi Dental is not on any of our India lists this week.

Laxmi Dental Ltd earned ₹10.0 Cr of net profit in the Jun 2026 quarter, +25.0% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹29.0 Cr. That is 13.3% of the quarter's revenue. The same quarter a year earlier earned ₹8.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹29.0 Cr (−9.4% on the year before).

Why profit moved: revenue changed +13.6% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +41.3% and revenue +16.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Laxmi Dental Ltd reported ₹75.0 Cr of revenue in the Jun 2026 quarter, +13.6% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 6 years it has grown 10.8% a year on average. The last full year, FY26, came in at ₹278 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹287 Cr.

FY26 revenue was ₹278 Cr, +16.3% on the year before.

Recent pace: the last four quarters grew +16.9% on average, against 10.8% a year over the longer run, so this year is growing faster than its own long-run rate.

Laxmi Dental Ltd's operating margin was 19.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between 2.3% and 18.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +1.1 percentage points on the year while gross margin changed +5.3 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 55% of Laxmi Dental Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 its operations used ₹5.0 Cr of cash, against ₹29.0 Cr of profit. After ₹28.0 Cr of spending on assets, free cash was −₹33.0 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 55% of profit came in as cash: the cash cycle got 51 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 51 days longer. The next section looks at where the cash is stuck.

Laxmi Dental Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 147 days in FY26, up from 96 days in FY21. It spent ₹66.0 Cr on assets over the last 3 years. Customers take 60 days to pay, and stock sits for 156 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹278 Cr, each day of that cycle ties up about ₹0.8 Cr, so roughly ₹112 Cr is tied up in the business at any time.

FY26: customers took 60 days to pay and stock sat for 156 days, about 5.1 months of sales sitting as stock, for a full cycle of 147 days, longer than FY21's 96.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 156 days. Customers pay about 60 days after that. Suppliers are paid at 68 days. Together that makes the 147-day cycle.

Spending on assets: ₹66.0 Cr over the last 3 years, against ₹43.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

Laxmi Dental Ltd's P/E is 29.8×, near the low end of its own history: it has been lower only 21% of the time. Its usual P/E (the middle reading) is 50.9×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹5.61.

Why the multiple is where it is: over the past year earnings per share moved −8.8% while the price moved −39.5%. Earnings did better than the price, which pulled the multiple down within its own range.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Laxmi Dental Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 8 quarters of 1 measure, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Laxmi Dental Ltd earned a ROCE of 15% in FY26. That is up from a low of −1% in FY22. Its return on capital used (ROIC) is 0.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 10.4% net margin and 0.94× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 10.4% net margin × 0.94× asset turnover × 1.22× leverage (assets divided by equity) ≈ 11.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 12.2% − 12.0% = +0.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

The 12.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 17.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Laxmi Dental Ltd has total debt of ₹13.0 Cr against shareholder equity of ₹244 Cr as of Jun 2026, so its debt is 0.05× its equity, which is very little. Year by year, that ratio went from 1.11 in FY24 to 0.06 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Foreign institutions cut their stake in Laxmi Dental Ltd by 27.7 percentage points over 6 quarters, the biggest change among its owners. Foreign institutions now own 6.6% of the company. Domestic institutions moved −2.2 points over the same period, to 10.7%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −27.7 points over 6 quarters, to 6.6%; Domestic institutions: −2.2 points over 6 quarters, to 10.7%; Promoters: +0.0 points over 6 quarters, to 41.8%.

Why the owners changed: foreign institutions drove it (−27.7 points), together with domestic institutions (−2.2 points). They reduced their stake.

For Laxmi Dental Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

54.8 out of 100, rank 1 of 6 in Medical Equipment, with 68% of the evidence available.

Laxmi Dental Ltd scores 54.8 out of 100 against the 6 companies it is compared with in Medical Equipment, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 20.4 + 16 + 10.9 + 7.5 = 54.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Laxmi Dental ranks 1 of 6 Medical Equipment companies on the 4-Factor Sector Score, with 54.8 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Equipment, all 6 compared on one page.

Laxmi Dental is the 3rd largest of 6 Medical Equipment companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Poly Medicure and Tarsons Products. Just below it: Hemant Surgical Industries, Vasa Denticity and Prevest Denpro.

Medical Equipment companies close in size

1. Poly Medicure Ltd ₹14,692 crore
2. Tarsons Products Ltd ₹1,548 crore
3. Laxmi Dental Ltd ₹977 crore
4. Hemant Surgical Industries Ltd ₹916 crore
5. Vasa Denticity Ltd ₹754 crore
6. Prevest Denpro Ltd ₹510 crore

All 6 Medical Equipment companies, largest first

Companies close in size in other industries

1614. IRM Energy Ltd ₹988 crore · LPG Bottling
1615. Arihant Capital Markets Ltd ₹979 crore · Finance - Capital Markets - Brokers
1616. Laxmi Dental Ltd ₹977 crore
1617. AceVector Ltd ₹976 crore
1618. Bharat Wire Ropes Ltd ₹975 crore · Steel - Wires

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.